Pegavision Corp. stock analysis
Pegavision Corp. (6491) Stock Price & Analysis
6491 Stock Chart & Stats
- Day’s Range
- TWD 362.50 - TWD 402.50
- 52-Week Range
- TWD 270.50 - TWD 437.00
- Previous Close
- TWD 399.50
- Volume
- N/A
- Average Volume (3M)
- 372.75K
- Market Cap
- TWD 30.61B
- Enterprise Value
- TWD 29.87B
- Total Cash (Recent Filing)
- TWD 3.77B
- Total Debt (Recent Filing)
- TWD 1.14B
- Price to Earnings (P/E)
- 15.1
- Beta
- 0.51
- Next Earnings
- Mar 12, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Aug 07, 2026
- Dividend Yield
- 2.55%
Bulls Say, Bears Say
Bulls Say
Strong Profitability
High gross, operating, and net margins indicate that Pegavision converts revenue into substantial earnings and retains meaningful economics in its core eye-care products. This profitability provides internal funding capacity and a durable cushion against moderate cost or mix pressure.
Low Financial Leverage
The very low debt burden reduces financial risk and limits the amount of earnings absorbed by interest costs. A strong equity base gives Pegavision flexibility to fund operations and investment while remaining better positioned to withstand weaker business conditions.
Revenue And Earnings Growth
Strong reported revenue growth, alongside faster EPS growth, shows that Pegavision has recently expanded its business while increasing earnings at an even stronger rate. If this operating trajectory persists, it can support reinvestment and strengthen the company’s market position.
Bears Say
Weak Cash Conversion
Operating cash flow materially below reported net income reduces confidence that accounting profits are translating efficiently into cash. This can constrain internally funded investment and may reflect working-capital needs or timing effects that remain relevant to earnings quality.
Volatile Free Cash Flow
The sharp year-over-year decline and prior negative free cash flow indicate that cash generation has not been consistently aligned with profitability. Continued volatility could reduce financial flexibility and make funding growth or shareholder returns more dependent on operating improvement.
Margin Softening
Recent margin moderation suggests that higher costs or an unfavorable product mix may be tempering the benefits of revenue growth. If this pressure persists, it could limit operating leverage and prevent future earnings from growing as quickly as sales.
6491 FAQ
What was Pegavision Corp.’s price range in the past 12 months?
What is Pegavision Corp.’s market cap?
When is Pegavision Corp.’s upcoming earnings report date?
How were Pegavision Corp.’s earnings last quarter?
Is Pegavision Corp. overvalued?
Does Pegavision Corp. pay dividends?
What is Pegavision Corp.’s EPS estimate?
How many shares outstanding does Pegavision Corp. have?
What happened to Pegavision Corp.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Pegavision Corp.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Pegavision Corp.
Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation is a subsidiary of Kinsus Interconnect Technology Corp.
- Sector
- General
- Industry
- Medical - Instruments & Supplies
- CEO
- Te Sheng Yang
- Employees
- 9,425
- Website
- www.pegavision.com
- Address
- No.5, Shing Yeh Street, Taoyuan City, TPE, 33341, TW
Pegavision Corp. (6491) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 5 | 10 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 4 | 0 | 8 |

